Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PALI
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Robert Baltera Jr. Director | PALI Palisade Bio, Inc. | Buy | 25,000 | $1.96 | $49.0K Buy | Form 4 ↗ |
| Jul 8, 2026 | Robert Baltera Jr. Director | PALI Palisade Bio, Inc. | Buy | 20,000 | $1.99 | $39.8K Buy | Form 4 ↗ |
| Jul 7, 2026 | Robert Baltera Jr. Director | PALI Palisade Bio, Inc. | Buy | 30,000 | $2.03 | $60.9K Buy | Form 4 ↗ |
| Jul 7, 2026 | Mitchell Lawrence Jones Chief Medical Officer | PALI Palisade Bio, Inc. | Sale | 51,880 | $2.05 | $106.4K Sale | Form 4 ↗ |
| Jul 7, 2026 | John David Finley CEO, CFO, Director | PALI Palisade Bio, Inc. | Sale | 146,798 | $2.07 | $303.9K Sale | Form 4 ↗ |
| Jul 6, 2026 | Robert Baltera Jr. Director | PALI Palisade Bio, Inc. | Buy | 20,000 | $2.05 | $41.0K Buy | Form 4 ↗ |
| Jul 2, 2026 | Robert Baltera Jr. Director | PALI Palisade Bio, Inc. | Buy | 10,000 | $1.98 | $19.8K Buy | Form 4 ↗ |
| Jul 1, 2026 | Robert Baltera Jr. Director | PALI Palisade Bio, Inc. | Buy | 20,000 | $1.98 | $39.6K Buy | Form 4 ↗ |
| Feb 12, 2026 | Mitchell Lawrence Jones Chief Medical Officer | PALI Palisade Bio, Inc. | Sale | 1,989 | $1.75 | $3,481 Sale | Form 4 ↗ |
| Feb 12, 2026 | John David Finley CEO, CFO, Director | PALI Palisade Bio, Inc. | Sale | 3,896 | $1.75 | $6,818 Sale | Form 4 ↗ |
| Jan 16, 2026 | Donald Allen Williams Director | PALI Palisade Bio, Inc. | Buy | 5,000 | $1.67 | $8,350 Buy | Form 4 ↗ |
| Jan 9, 2026 | Donald Allen Williams Director | PALI Palisade Bio, Inc. | Buy | 5,000 | $1.88 | $9,400 Buy | Form 4 ↗ |
12 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:41 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances